M-A: Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma.
7 Mar, 2022 | 00:07h | UTC
Commentary from the author on Twitter (thread – click for more)
In this global study of NAFLD-related HCC, we determine:
1.Prevalence
2.Clinical characteristics
3.% cirrhosis
4.Surveillance
5.Treatment allocation
6.Outcomes#LiverCancerSIG #LivertwitterFree to read @TheLancetOncol https://t.co/vwAeicpWxq
1/n pic.twitter.com/gM1BHVSwXl
— Daniel Huang (@DrHuangDQ) March 4, 2022